PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.42%
Revenue growth at 50-75% of 3141.T's 14.79%. Martin Whitman would worry about competitiveness or product relevance.
8.17%
Gross profit growth at 50-75% of 3141.T's 11.98%. Martin Whitman would question if cost structure or brand is lagging.
-1.82%
Negative EBIT growth while 3141.T is at 4.35%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
18.93%
Operating income growth above 1.5x 3141.T's 9.73%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1.60%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
1.65%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1.65%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3141.T is at 19.57%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 19.57%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
99.82%
Maintaining or increasing dividends while 3141.T cut them. John Neff might see a strong edge in shareholder returns.
-52.95%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-67.96%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
15.33%
Positive 10Y revenue/share CAGR while 3141.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
15.33%
Positive 5Y CAGR while 3141.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
15.33%
Positive 3Y CAGR while 3141.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
129.00%
Positive long-term OCF/share growth while 3141.T is negative. John Neff would see a structural advantage in sustained cash generation.
129.00%
Positive OCF/share growth while 3141.T is negative. John Neff might see a comparative advantage in operational cash viability.
129.00%
Positive 3Y OCF/share CAGR while 3141.T is negative. John Neff might see a big short-term edge in operational efficiency.
8.12%
Net income/share CAGR above 1.5x 3141.T's 1.96% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
8.12%
5Y net income/share CAGR above 1.5x 3141.T's 1.96%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
8.12%
3Y net income/share CAGR above 1.5x 3141.T's 1.96%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
53.20%
Dividend/share CAGR of 53.20% while 3141.T is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
53.20%
Dividend/share CAGR of 53.20% while 3141.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
53.20%
3Y dividend/share CAGR of 53.20% while 3141.T is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
No Data
No Data available this quarter, please select a different quarter.
-4.73%
Inventory is declining while 3141.T stands at 12.94%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.98%
Asset growth well under 50% of 3141.T's 9.76%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.13%
Positive BV/share change while 3141.T is negative. John Neff sees a clear edge over a competitor losing equity.
-24.33%
We’re deleveraging while 3141.T stands at 15.33%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.